Psoriasis treatments may impact your bones – new study reveals

This study looked at 100 adults with moderate-to-severe psoriasis to see how two biologic drugs, Secukinumab and Adalimumab, affect bone density. Psoriasis is a chronic inflammatory condition that can raise the risk of weak bones (osteopenia or osteoporosis). Researchers measured bone mineral density in the spine and hip over time to compare the bone effects of these treatments. The goal is to help doctors choose the best therapy for patients at risk of bone loss.